Locations:
Search IconSearch
February 10, 2023/Cancer/Research

Novel Therapeutics Clinic Offers Access to Early-Phase Trials for Solid Tumors

Dedicated investigators and clinicians bring expertise in drug development and flexible study design

Novel Therapeutics Clinic

To increase access to emerging cancer therapeutics and improve convenience for patients and researchers, Taussig Cancer Institute opened a dedicated Novel Therapeutics Clinic. Located on the main Cleveland Clinic campus in the Taussig Cancer Center, the new clinic provides access to early-phase trials of novel agents, including immunotherapies, cell and gene therapies, small molecule drugs, new radiation therapy modalities as well as viral therapies, for a wide range of solid tumors.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The clinical team includes physicians who are experts in pharmacology, immunotherapy and regulatory science, as well as pharmacists, research nurses and nurse coordinators dedicated to early-phase trials. The physicians bring expertise in breast, lung, head and neck, melanoma, sarcoma, gastro-intestinal, genitourinary, and rare cancers. Together, they serve the needs of patients with certain mutations that may respond well to a particular targeted treatment, as well as patients who have not found standard of care options effective.

Shared knowledge across clinical research

The clinic’s multidisciplinary approach can help accelerate research and bring efficiencies to cancer care. Instead of researchers specializing in different solid tumor types operating in silos, they work alongside one another in a dedicated novel cancer therapeutics unit in evaluating, treating and managing patients enrolled in early-phase trials.

“A key attribute to a successful novel cancer therapeutics program is the organized presence of a dedicated group of clinicians with an interest and expertise in drug development,” says Taussig Cancer Institute Chair Alex A. Adjei, MD, PhD. “They are immersed in the science, and have a deep understanding of the mechanisms of action, side effects and other characteristics of the study drugs.”

Centralizing care

The goal of the Novel Therapeutics Clinic is to centralize and coordinate the care of patients being evaluated for or receiving treatment on early-phase cancer therapeutic trials, including phase I or phase I/II studies. Instead of patients going from clinic to clinic to see different providers, they have the convenience of seeing all of their care team, including oncology specialists, nurses and research coordinators, in one place. Palliative care physicians and nurses are also available for symptom management support.

Advertisement

Reducing barriers to care

The clinic team is applying its experience with flexible study designs to help remove common obstacles to clinical trial participation. Often patients who live far from academic centers of excellence or who have transportation issues may be reluctant to participate in trials. To help support these patients, the clinic is making initial consultations possible via phone or virtual visits, and when possible, is working to reduce the number of in-person visits that are necessary for trial participation.

The Novel Therapeutics Clinic is also working to remove financial barriers that lead to health inequities. “We aren’t going to turn away a patient because they’re underinsured or because they don’t have insurance,” says Dr. Adjei. “Our goal is to provide resources to help patients through those situations.”

From the first call to the Cleveland Clinic Cancer Answer Line, a dedicated care coordinator and financial navigator works with patients and physicians to help them navigate medical cost issues. This may include reviewing benefit design, helping patients understand insurance and hospital care assurance program (HCAP) benefits, identifying the best coverage options for their specific needs, checking for insurance approvals and identifying additional financial supports. Financial navigators are an extra resource that can help to identify potential assistance programs, including those providing assistance with medications, housing and utilities.

When a patient is referred to the clinic, a team of specialists reviews the clinical trial options selected for the patient. They help identify the most appropriate trial for the patient based on their type of tumor and the genetic abnormalities or pathology features of the tumor. From there, they work together with the referring physician for coordinated care of the patient.

Advertisement

Learn more about the Novel Therapeutics Clinic in our recent podcast.

For more information, contact the Cleveland Clinic Cancer Answer Line at 866-223-8100 or complete a referral form.

Advertisement

Related Articles

Illustration of a brain
November 6, 2024/Neurosciences/Research
Genomic Analysis Finds Connections Between Transposable Elements and Alzheimer's Disease

Understanding TE involvement is a key to developing new treatments

Nurses at nursing conference, poster presentation
October 25, 2024/Nursing/Research
The Power of Publishing Your Clinical and Research Work

How nurses can effect change through professional writing

Portrait of nurse Karen Schaedlich
October 11, 2024/Nursing/Innovations
Turning Ideas into Innovations (Podcast)

Nurses who embrace innovation can solve problems and improve healthcare for patients and caregivers

Dr. Imad Najm against a decorative background
September 16, 2024/Neurosciences/Podcast
Temporal Lobe Epilepsy and the Potential of Gene Therapy (Podcast)

Investigational gene approaches offer hope for a therapeutically challenging condition

neurons, axons and synapses in the brain
September 5, 2024/Neurosciences/Research
A Case Study in Neurotherapeutic Clinical Trial Design and Conduct

New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities

patient's blood pressure being checked
August 5, 2024/Pulmonary/Critical Care
Why Can’t Patient Outcomes Be Predicted More Like the Weather?

Dynamic modeling improves the accuracy of outcome predictions for ICU patients

Matthew Kroh, MD with surgeons
July 5, 2024/Digestive/Innovation
How the Digestive Disease Innovations Program Empowers Caregivers to Be Ambassadors for Innovation

Insights from Cleveland Clinic’s Vice Chair of Innovation and Technology

Dr. Grobmyer and team
June 14, 2024/Cancer/Innovations
Fatima bint Mubarak Center Addresses Inequities in Cancer Care

Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates

Ad